Amexdrug Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jul '25 Jul 29, 2025	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Market Capitalization	0	8	17	17	19	9
Market Cap Growth	-99.83%	-50.01%	-0.01%	-9.10%	115.38%	-15.00%
Enterprise Value	-	9	17	17	19	9
Last Close Price	0.00	0.05	0.10	0.10	0.11	0.05
PE Ratio	0.20	103.08	168.06	89.47	1014.33	700.61
PS Ratio	0.00	0.92	1.36	1.47	1.91	1.52
PB Ratio	0.05	19.68	48.52	67.53	292.58	158.41
P/TBV Ratio	0.05	20.56	51.26	73.00	416.76	243.90
P/FCF Ratio	-	-	-	75.94	-	-
P/OCF Ratio	-	-	-	74.59	-	-
EV/Sales Ratio	-	1.01	1.38	1.47	1.94	1.54
EV/EBITDA Ratio	-	42.99	74.98	56.72	296.36	173.55
EV/EBIT Ratio	-	47.28	77.15	58.30	340.21	262.81
EV/FCF Ratio	-	-	-	76.02	-	-
Debt / Equity Ratio	1.46	2.79	2.13	1.67	4.92	3.68
Debt / EBITDA Ratio	2.52	5.57	3.26	1.40	4.89	3.97
Debt / FCF Ratio	-	-	-	1.88	-	-
Net Debt / Equity Ratio	1.21	1.81	0.43	-0.13	2.90	1.86
Net Debt / EBITDA Ratio	2.08	3.61	0.66	-0.11	2.88	2.01
Net Debt / FCF Ratio	-1.48	-1.26	-0.84	-0.15	-2.52	-0.52
Asset Turnover	4.99	4.57	8.44	10.74	12.96	8.11
Inventory Turnover	11.76	16.30	45.43	45.56	48.98	25.80
Quick Ratio	0.67	0.60	1.00	0.85	0.79	0.64
Current Ratio	1.35	1.14	1.20	1.19	1.02	1.01
Return on Equity (ROE)	28.78%	21.08%	33.60%	120.38%	31.06%	25.49%
Return on Assets (ROA)	11.25%	6.11%	9.41%	16.96%	4.62%	2.97%
Return on Invested Capital (ROIC)	12.82%	11.79%	33.26%	88.72%	18.60%	49.11%
Return on Capital Employed (ROCE)	34.40%	25.60%	63.50%	115.90%	87.60%	61.10%
Earnings Yield	490.33%	0.97%	0.60%	1.12%	0.10%	0.14%
FCF Yield	-1584.27%	-7.32%	-1.06%	1.32%	-0.39%	-2.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.